The comparison of effects of two drugs in neutropenic patients
Phase 2
Completed
- Conditions
- eutropenia.Neutropenia
- Registration Number
- IRCT201205279875N1
- Lead Sponsor
- Cinnagen Drug Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Patients with leukemia or solid tumor; Neutropenia due to infection or chemotherapy
Exclusion criteria: Patients with drug reaction to investigation drugs; Failure to refer the patients to follow up.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Absolute Neutrophil Count. Timepoint: A week followig end of treatment. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method Drug side effect. Timepoint: 7 days after treatment. Method of measurement: Physical Examination.